Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $3.2M
9 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
11 people
Capital Cell
BarcelonaPre-Seed–Growth
Kernel Capital
CorkSeed–Late Stage$1.1M – $5.4M
9 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Clay Capital
Seed–Late Stage$3M – $8M
16 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
Kelvin Capital
GlasgowSeed–Late Stage
8 people
AMR Action Fund
BostonSeed–Series C
13 people
Export and Investment Fund
CopenhagenPre-Seed–Growth$108K – $7.6M
16 people
Scion Life Sciences
New YorkPre-Seed–Late Stage$1K – $60M
13 people
Seroba Life Sciences
DublinSeed–Late Stage$540K – $7.6M
13 people
Quadrille Capital
ParisSeed–Late Stage
17 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
11 people
Perivoli Innovations
St. HelierPre-Seed–Growth
2 people
Starfish Ventures
MelbournePre-Seed–Growth$2M – $3.3M
2 people
LifeArc Ventures
LondonSeed–Growth
12 people
SIB Innovations- und Beteiligungsgesellschaft
DresdenSeed–Late Stage$54K – $10.8M
6 people
MDI Ventures
JakartaPre-Seed–Growth$500K – $75M
11 people
Hikma Ventures
LondonSeed–Late Stage$5M
13 people
Tin Alley Ventures
MelbournePre-Seed–Late Stage
14 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
DCVC Bio
Palo AltoSeed–Growth
15 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.